Slager David Mark 13D/13G Filings for Pluristem Therapeutics Inc. (PSTI)

Slager David Mark 13D and 13G filings for Pluristem Therapeutics Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-01-26
1:52 pm
Purchase
2022-01-2413GPluristem Therapeutics Inc.
PSTI
Slager David Mark1,685,038
5.250%
1,685,038increase
(New Position)
Filing